BioSpace News Archive

Policy

AHF: Drug Industry Sends its Shills to Senate Hearing on Drug Prices

Pharmaceutical CEOs too cowardly to appear before Senate Finance Committee; lackeys instead try to blame the 340B drug discount program, which is only a tiny sliver of the $457 billion U.S. drug market

January 29, 2019
·
2 min read
Business

HOX THERAPEUTICS APPOINTS STEPHEN SHUTTLEWORTH AS NON-EXECUTIVE DIRECTOR

HOX Therapeutics, the private biotechnology company developing first-in-class, highly targeted cancer therapies based on HOX genes, announces the appointment of Dr Stephen Shuttleworth as Non-Executive Director.

January 29, 2019
·
3 min read
FDA

Qualigen Receives FDA Clearance for its FastPack® IP SHBG Assay

Qualigen, Inc. announced that the Company has received clearance from the U.S. Food and Drug Administration for its FastPack IP Sex Hormone Binding Globulin Immunoassay.

January 29, 2019
·
1 min read
Biotec Pharmacon finalises Post Market study on Woulgan

Biotec Pharmacon’s (OSE: Biotec) has announced that its subsidiary, Biotec BetaGlucans, has finalised treatment in a UK Post Market Clinical Follow-up (PMCF) study on its wound care gel, Woulgan®, in diabetic foot ulcer patients.

January 29, 2019
·
3 min read
Pharm Country

PUTNAM PLASTICS INTRODUCES RILSLIX™ COATINGS FOR MEDICAL MANDRELS AND CONTINUOUS WIRE

Putnam Plastics Corporation, a leader in advanced extrusion for minimally invasive medical devices, has expanded their product portfolio to include RilSlix™ coated mandrels and wires.

January 29, 2019
·
2 min read
Business

Array BioPharma to Report Financial Results for the Second Quarter of Fiscal 2019 on February 5, 2019

Array BioPharma, Inc. will report financial results for the second quarter of fiscal 2019 and hold a conference call to discuss those results on Tuesday, February 5, 2019.

January 29, 2019
·
1 min read
Business

Amgen Reports Fourth Quarter And Full Year 2018 Financial Results

Amgen announced financial results for the fourth quarter and full year 2018 in comparison to comparable periods in 2017.

January 29, 2019
·
31 min read
Business

Bioasis Announces Filing of Its Quarterly Financial Statements and MD&A for the Period Ending November 30, 2018

BIOASIS TECHNOLOGIES INC. announced that it has filed its unaudited quarterly financial statements and management’s discussion and analysis for the period ended Nov. 30, 2018.

January 29, 2019
·
1 min read
Business

Metrion Biosciences and LifeArc sign collaboration agreement for neuroscience-focused ion channel drug discovery

Metrion Biosciences Limited (Metrion), the specialist ion channel CRO and drug discovery company, and LifeArc, a leading UK medical research charity, today announced they have entered into a collaboration agreement for an ion channel drug discovery project in the field of neuroscience

January 29, 2019
·
3 min read
BioMidwest

Clinical Architecture Announces the Release of Symedical® 2.1

Focusing on Improving Data Quality and Enabling Meaningful Clinical Insights

January 29, 2019
·
3 min read